✦ LIBER ✦

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Scribed by Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga

Book ID: 108641685
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 739 KB
Volume: 62
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2006.02741.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of peginterferon alf

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis

Early virologic response after peginterf

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

✍ A. M. Di Bisceglie; R. H. Ghalib; F. M. Hamzeh; V. K. Rustgi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Sustained virological response to pegint

Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response

✍ M. TRAPERO-MARUGÁN; L. GARCÍA-BUEY; C. MUÑOZ; N. E. QUINTANA; J. A. MORENO-MONTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Peginterferon alfa-2a and ribavirin for

Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response

✍ C. D. Howell; L. S. Jeffers; W. Cassidy; K. R. Reddy; S. Hu; J. S. Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Pretreatment prediction of virological r

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors

✍ Haruaki Shirakawa; Akihiro Matsumoto; Satoru Joshita; Michiharu Komatsu; Naoki T 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

Peginterferon alpha-2a is associated wit

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials

✍ Tahany Awad; Kristian Thorlund; Goran Hauser; Davor Stimac; Mahasen Mabrouk; Chr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 1 views

A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin represents the standard of care for the treatment of chronic hepatitis C according to current guidelines. It is not established which of the two licensed products (peginterferon alpha-2a or peginterferon alfa-2b)